May 8 – 10, 2018

Boston, MA

3D TM Oncology Header

3DOncology Test
3DOncology Test (2)
3DOncology Test (1)

Empowering Cancer Drug Research Through the Application of 3D Tissue Models

The advent of 3D models has presented a new dimension to cancer research. Despite this enormous potential, concerns related to their utility within discovery and development must be addressed before adoption and more importantly, regulatory acceptance is seen.

3D Tissue Models: Oncology explored the technical and cultural challenges at the crux of your research efforts. We explored the very latest industry-driven insights and data on the application of these systems across cancer drug research.

What made this event unique?

symbol logo A concerted attempt to provide an ambiance at the conference that encourages interaction, exchange of ideas and networking opportunities among all participants.
symbol logo A high-quality scientific program dedicated to exploring the applicability of spheroids, organoids, PDX and chip-based platforms in IO and oncology.
symbol logo A multidisciplinary mix of participants representing consortia, leading scientists and pharmaceutical business leaders.

Missed this event? Why not check out PREDiCT: 3D Models